Functional Characterization of Lysophospholipids by Proteomic and Lipidomic Analysis of Fibroblast-like Synoviocytes

dc.contributor.authorTimm, Thomas
dc.contributor.authorHild, Christiane
dc.contributor.authorLiebisch, Gerhard
dc.contributor.authorRickert, Markus
dc.contributor.authorLochnit, Guenter
dc.contributor.authorSteinmeyer, Juergen
dc.date.accessioned2023-09-21T07:56:20Z
dc.date.available2023-09-21T07:56:20Z
dc.date.issued2023
dc.description.abstractSynovial fluid (SF) from human knee joints with osteoarthritis (OA) has elevated levels of lysophosphatidylcholine (LPC) species, but their functional role is not well understood. This in vitro study was designed to test the hypothesis that various LPCs found elevated in OA SF and their metabolites, lysophosphatidic acids (LPAs), modulate the abundance of proteins and phospholipids (PLs) in human fibroblast-like synoviocytes (FLSs), with even minute chemical variations in lysophospholipids determining the extent of regulation. Cultured FLSs (n = 5–7) were treated with one of the LPC species, LPA species, IL-1β, or a vehicle. Tandem mass tag peptide labeling coupled with LC-MS/MS/MS was performed to quantify proteins. The expression of mRNA from regulated proteins was analyzed using RT-PCR. PL synthesis was determined via ESI-MS/MS, and the release of radiolabeled PLs was determined by means of liquid scintillation counting. In total, 3960 proteins were quantified using multiplexed MS, of which 119, 8, and 3 were significantly and reproducibly regulated by IL-1β, LPC 16:0, and LPC 18:0, respectively. LPC 16:0 significantly inhibited the release of PLs and the synthesis of phosphatidylcholine, LPC, and sphingomyelin. Neither LPC metabolite—LPA 16:0 nor LPA 18:0—had any reproducible effect on the levels of each protein. In conclusion, small chemical variations in LPC species can result in the significantly altered expression and secretion of proteins and PLs from FLSs. IL-1β influenced all proteins that were reproducibly regulated by LPC 16:0. LPC species are likely to modulate FLS protein expression only in more advanced OA stages with low IL-1β levels. None of the eight proteins being significantly regulated by LPC 16:0 have been previously reported in OA. However, our in vitro findings show that the CD81 antigen, calumenin, and B4E2C1 are promising candidates for further study, focusing in particular on their potential ability to modulate inflammatory and catabolic mechanisms.
dc.description.sponsorshipDeutsche Forschungsgemeinschaft (DFG); ROR-ID:018mejw64
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/18492
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-17856
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectlysophosphatidylcholine
dc.subjectlysophospholipid
dc.subjectproteomics
dc.subjectlipidomics
dc.subjectphospholipids
dc.subjectlipids
dc.subjectefflux
dc.subjectinflammation
dc.subjectorbitrap
dc.subjectfunctions
dc.subjectosteoarthritis
dc.subjectfibroblast-like synoviocytes
dc.subject.ddcddc:610
dc.titleFunctional Characterization of Lysophospholipids by Proteomic and Lipidomic Analysis of Fibroblast-like Synoviocytes
dc.typearticle
local.affiliationFB 11 - Medizin
local.projectgrant no. 426546972
local.source.articlenumber1743
local.source.epage18
local.source.journaltitleCells
local.source.spage1
local.source.urihttps://doi.org/10.3390/cells12131743
local.source.volume12

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.3390_cells12131743.pdf
Größe:
2 MB
Format:
Adobe Portable Document Format